Journal Title
JOURNAL OF IMMUNOTHERAPY

J IMMUNOTHER

ISSN / eISSN
1524-9557 / 1537-4513
Aims and Scope
Journal of Immunotherapy features rapid publication of articles on immunomodulators, lymphokines, antibodies, cells, and cell products in cancer biology and therapy. Laboratory and preclinical studies, as well as investigative clinical reports, are presented. The journal emphasizes basic mechanisms and methods for the rapid transfer of technology from the laboratory to the clinic. JIT contains full-length articles, review articles, and short communications.
Subject Area

IMMUNOLOGY

MEDICINE, RESEARCH & EXPERIMENTAL

ONCOLOGY

CiteScore
7.50 View Trend
CiteScore Ranking
Category Quartile Rank
Pharmacology, Toxicology and Pharmaceutics - Pharmacology Q1 #75/301
Pharmacology, Toxicology and Pharmaceutics - Immunology and Allergy Q2 #70/211
Pharmacology, Toxicology and Pharmaceutics - Immunology Q2 #79/217
Pharmacology, Toxicology and Pharmaceutics - Cancer Research Q2 #80/214
Web of Science Core Collection
Science Citation Index Expanded (SCIE) Social Sciences Citation Index (SSCI)
Indexed -
Category (Journal Citation Reports 2023) Quartile
IMMUNOLOGY - SCIE Q3
MEDICINE, RESEARCH & EXPERIMENTAL - SCIE Q3
ONCOLOGY - SCIE Q2
H-index
89
Country/Area of Publication
UNITED STATES
Publisher
Lippincott Williams and Wilkins Ltd.
Publication Frequency
Monthly
Year Publication Started
1997
Annual Article Volume
51
Open Access
NO
Contact
LIPPINCOTT WILLIAMS & WILKINS, 530 WALNUT ST, PHILADELPHIA, USA, PA, 19106-3621

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More